All Valeant articles
-
Blog
Tone at the top really does matter
The Man From FCPA Tom Fox looks at the case of disgraced pharmaceutical company Valeant and what new Chief Financial Officer Paul Herendeen has planned for the company’s future.
-
Blog
Tone at the top and (former) CEO consulting
What does retaining a disgraced CEO as a consultant tell you about tone at the top?
-
Blog
Where Valeant, and Corporate America, Went Wrong
Image: The big political story this week was the Republican presidential debate, and candidates’ usual complaints that too many Americans are falling behind economically. The big corporate governance story, meanwhile, has been the unraveling of Valeant Pharmaceuticals. The two are tied, Compliance Week editor Matt Kelly writes—since Valeant’s misplaced corporate ...